Pfizer, Starboard Value
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to ...
Greek dry bulk operator Starboard has contracted a panamax for a year as Clarksons data showed period rates in the sector are ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback